Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
WOBURN, Mass. May 6, 2024 – Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products...
US FDA Approves High-Concentration, Citrate-Free Formulation of Cyltezo (adalimumab-adbm) injection
Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of...
There's a New Set of COVID Variants Called FLiRT: What You Need to Know
The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has reported.The...
Drive to Be 'Perfect' Parent Isn't Healthy, Survey Finds
Parents striving to be “perfect” will never attain that goal, and the aim isn’t even healthy for their families, a new study says.The risks of striving...
How Bad Was Beethoven's Lead Poisoning?
No one knows what caused the liver and kidney disease that led to Ludwig van Beethoven’s untimely death.But one popular theory – that high lead levels...
Big Rise in Emergencies Involving Synthetic Weed Among Kids, Adults
Calls to U.S. poison centers regarding so-called synthetic cannabis jumped 88% between 2021 and 2022, as use of these legally sold products rose, research...
Most Socially Vulnerable Counties Less Likely to Have Cancer Trials
The most socially vulnerable counties are less likely to have any cancer clinical trial, according to a research letter published online May 7 in JAMA...
Excess Gestational Weight Gain Common in Military Health Beneficiaries
Military health beneficiaries, especially active-duty personnel, more often have excessive gestational weight gain (GWG), according to a study published...
Listeria Risk Prompts Recall of Planters Peanut Products
Planters Honey Roasted Peanuts and Planters Deluxe Lightly Salted Mixed Nuts, sold at Publix and Dollar Tree in five states, are being recalled due to...
Surgical Premature Menopause Tied to Risk for Muscle Disorders
Women experiencing surgical premature menopause (PM) have a higher likelihood of developing musculoskeletal disorders, according to a study published online...
Positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
STOCKHOLM, May 6, 2024. Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its...
Phase 2 data for Erleada plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localized prostate cancer results published
SAN ANTONIO, May 3, 2024. Johnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment...
An Orangutan Healed Himself With Medicinal Plant
Primates are capable of tending to wounds using medicinal plants, a new case report says. A male Sumatran orangutan treated a facial wound with a climbing...
Recently Added
Recently added consumer and prescribing information: Myhibbin, Rezenopy, Libervant, Beqvez, Xolremdi, Pivya, Xromi, Risvan, Voydeya, Winrevair
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Myhibbin Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used for the prophylaxis of organ rejection.
- Libervant Libervant (diazepam) is a buccal film formulation of the benzodiazepine diazepam that may be given to treat children aged 2 to 5 years with...
- Xolremdi Xolremdi (mavorixafor) is a CXC chemokine receptor 4 (CXCR4) antagonist indicated in patients 12 years of age and older with WHIM syndrome...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...